Optimising Expression Platforms track banner


The pursuit for biotherapeutic proteins in basic research, clinical diagnostics, and therapy continues at an exponential pace. Consequently, the demands for efficient expression and production of these valuable biomolecules face challenges to improve quantity and quality while minimising time and cost. Thus, an increasing variety of recombinant production platforms, called “cell factories,” are being developed. Unfortunately, there is no universal production system which can guarantee high yields, since each protein can vary in terms of expression and production.

The Optimising Expression Platforms program convenes protein expression and production specialists to share their real-world experiences and results.

We invite presentation proposals on the following preliminary topics with an emphasis on the desired biotherapeutic protein product -- including recombinant proteins, antibodies, membrane proteins, and difficult-to-express proteins.

Coverage will include, but is not limited to:

  • Cell Factories
    • Mammalian (CHO, HEK293, NS0)
    • Insect (Baculovirus, Drosophila)
    • Bacterial (Escherichia coli)
    • Yeast (Pichia pastoris, Saccharomyces cerevisiae)
    • Other (Algae, Tobacco)
  • Host Selection
  • Cloning Strategies
  • Biotherapeutic Proteins
    • Recombinant Proteins
    • Antibodies
    • Membrane Proteins
    • Difficult-to-Express Proteins
  • Matching Host to Protein of Choice
  • Re‐engineering Existing Systems for Better Performance
  • Automation for Higher Throughput
  • Faster Turnaround Times
  • Development of Analytical Assays to Determine Identity, Purity, and Biological Activity
  • Increasing Speed and Lowering Cost
  • Stable Expression vs. Transient Expression
  • Case Studies

If you would like to submit a proposal to give a presentation at this meeting, please click here.


The deadline for priority consideration is 10 April 2020.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

Mary Ann Brown

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: (+1) 781.972.5497

Email: mabrown@healthtech.com


For partnering and sponsorship information, please contact:

Companies A-K

Jason Gerardi

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781.972.5452

Email: jgerardi@healthtech.com


Companies L-Z

Ashley Parsons

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781.972.1340

Email: ashleyparsons@healthtech.com